Skip to content
← Index board

Health Optimization Index

Melanotan II

Nick’s assessment
Experimental
Research evidence
C, mixed evidence
Attention
28.5 / 100▲ Rising this week
4.5/ 10

BioHarmony score

Melanotan II is a fast tanning and sexual-response peptide with a harsher safety tradeoff; Nelson 2012 reported rhabdomyolysis after a 6 mg injection. Its appetite and libido effects may be noticeable, but this report treats unregulated use as high risk.

Read the full report Benefits, risks and practical guidance.

Read Nick’s assessment Why it earned this rating

Melanotan II is effective enough to tempt use and risky enough to demand restraint. It reliably tans skin, blunts appetite, and drives libido, but it does all of that by activating melanocortin receptors throughout the body, and the documented harms (PRES, rhabdomyolysis, renal infarction, melanoma, priapism) are too serious to wave off as ordinary tolerability issues. The score reflects the compound itself; sourcing and product-quality cautions sit in the notes below and are not folded into the dimension scores.

✅ Best for: Experienced users who already understand peptide sourcing, have a dermatologist watching their skin and moles, can recognize emergency symptoms, and treat MT-II as a short initiation tool rather than a chronic lifestyle product. It is most relevant when libido or appetite suppression is the actual goal, since those effects come from receptors that Melanotan I largely skips.

❌ Avoid if: You have a history of melanoma, atypical or changing moles, uncontrolled blood pressure, kidney disease, seizures or severe migraines, prior priapism, sickle-cell disease, or anticoagulant use without oversight, or if you are pregnant, breastfeeding, or far from urgent care. Also avoid nasal sprays and unlabeled vials when sterility, identity, dose accuracy, or contamination controls are unclear; those are supply-chain cautions, not part of the score.

Share your experience

Your answers are optional and help other readers — they never change my score. How community input works.

Tried it in real life?

How would you assess it?

Favorable is the strongest rating, followed by Promising, then Experimental. Overhyped means the claims outrun the evidence or interest is fading.

Make a 12-month prediction Will it rise or fall in the Index?

Choose a direction and your confidence. Correct predictions earn leaderboard points.

Your 12-month call on Melanotan II
How sure are you?

Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →

Updated Sep 21, 2026 How the Index ranks →

Educational information, not medical advice. Ask a qualified clinician about risks and interactions. Independent ratings: no affiliate links, sponsored placements or paid rankings.